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Abstract. 
 
We have compared cytoplasmic extracts 
from chicken DU249 cells at various stages along the 
apoptotic pathway. Extracts from morphologically nor-
mal “committed stage” cells induce apoptotic morphol-
ogy and DNA cleavage in substrate nuclei but require 
ongoing caspase activity to do so. In contrast, extracts 
from frankly apoptotic cells induce apoptotic events in 
added nuclei in a caspase-independent manner. Bio-
chemical fractionation of these extracts reveals that a 
column fraction enriched in endogenous active 
caspases is unable to induce DNA fragmentation or 
chromatin condensation in substrate nuclei, whereas a 
caspase-depleted fraction induces both changes. Fur-
ther characterization of the “execution phase” extracts 
revealed the presence of an ICAD/DFF45 (inhibitor of 
caspase-activated DNase/DNA fragmentation factor)-
inhibitable nuclease resembling CAD, plus another ac-
tivity that was required for the apoptotic chromatin 
condensation. Despite the presence of active caspases, 
committed stage extracts lacked these downstream ac-
tivities, suggesting that the caspases and downstream fac-
tors are segregated from one another in vivo during the 
latent phase. These observations not only indicate that 
caspases act in an executive fashion, serving to activate 
downstream factors that disassemble the nucleus rather 
than disassembling it themselves, but they also suggest 
that activation of the downstream factors (rather than 
the caspases) is the critical event that occurs at the tran-
sition from the latent to active phase of apoptosis.
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A
 
poptosis
 
 is a cellular disassembly pathway that is ac-
tivated by members of a distinct family of cysteine
proteases called caspases (Cohen, 1997; Nicholson
and Thornberry, 1997; Villa et al., 1997; Cryns and Yuan,
1998). Genetic analyses show clearly that caspases such as
CED-3 and caspase-3 are essential for apoptotic death
(Yuan and Horvitz, 1990; Kuida et al., 1996; Woo et al.,
1998). Nonetheless, the role of these enzymes in the death
pathway remains unclear. One recent study has suggested
that cells can activate caspases without undergoing apop-
tosis (Boise and Thompson, 1997). Conversely, even
though caspase inhibitors usually rescue cells from apop-
tosis (for review see Villa et al., 1997), cell death can occur
in response to proapoptotic stimuli in the presence of
these inhibitors (Xiang et al., 1996; McCarthy et al., 1997;
Lavoie et al., 1998).
Careful examination has revealed that cells dying in the
presence of caspase inhibitors display membrane blebbing
and cell surface alterations but no changes in nuclear mor-
phology (McCarthy et al., 1997). This observation suggests
that certain cytoplasmic hallmarks of apoptosis may be
triggered by enzymes other than caspases, but that nuclear
events require caspase activity. Consistent with this view,
cells from caspase-3–null mice (Woo et al., 1998) have
been reported to display plasma membrane changes and
cleavage of the nuclear protein poly(ADP-ribose) poly-
merase (PARP)
 
1
 
 when undergoing apoptosis, but not the
chromatin condensation and DNA cleavage that are char-
acteristic of apoptosis (Wyllie et al., 1980).
Although the preceding observations suggest that cas-
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Abbreviations used in this paper
 
: CAD, caspase-activated DNase; C/D
extract, nonapoptotic extract from cells in the condemned phase; DAPI,
4,6-diamidino-2-phenylindole; DFF, DNA fragmentation factor; E/X ex-
tract, apoptotic extract from execution phase cells; Fr-2 and Fr-3, fractions
2 and 3 from heparin–agarose chromatography of S/M extract; ICAD, in-
hibitor of CAD; S/M extract, proapoptotic extract from committed phase
cells; PARP, poly(ADP-ribose) polymerase.
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pases play a role in certain apoptotic events, particularly
those occurring in the nucleus, it is not known whether
caspases function in an executive role to initiate the apop-
totic pathway and leave the work of actually disassembling
the cell to other downstream factors, or whether they are
workhorses whose cleavage of key substrates drives cellu-
lar disassembly. Support for an executive role comes from
the observation that expression of the caspase cleavage
product of the actin-binding protein GAS2 triggers cytoskel-
etal changes similar to those seen in apoptosis (Brancolini
et al., 1995). Likewise, caspase cleavage of ICAD/DFF (in-
hibitor of caspase-activated DNase/DNA fragmentation
factor) releases the nuclease CAD, presumably allowing it
to enter the nucleus and degrade genomic DNA (Liu et
al., 1997; Enari et al., 1998; Sakahira et al., 1998). Thus,
certain products of caspase cleavage play important down-
stream roles in apoptotic events. On the other hand, nu-
merous important structural and nonstructural proteins
are also directly cleaved by caspases (Cohen, 1997; Nichol-
son and Thornberry, 1997; Porter et al., 1997; Villa et al.,
1997), supporting the alternative hypothesis that caspases
do the bulk of the work of cutting the cell apart themselves
(Martin and Green, 1995).
Current understanding of caspase function has been fa-
cilitated by the development of cell-free systems for the
study of apoptosis (Lazebnik et al., 1993; Solary et al.,
1993; Newmeyer et al., 1994; Enari et al., 1995
 
a
 
; Martin et
al., 1995; Schlegel et al., 1995; Liu et al., 1996). One such
system uses extracts from DU249 chicken hepatoma cells
that become committed to apoptosis after perturbation of
the cell cycle (Lazebnik et al., 1993). Highly concentrated
cytosolic extracts prepared from these morphologically
normal cells (S/M extracts) reproduce all of the biochemi-
cal features of apoptosis in substrate nuclei (Lazebnik et
al., 1993), including genome digestion (Wyllie et al., 1980;
Lazebnik et al., 1993);
 
 
 
cleavage of a subset of nuclear pro-
teins, including PARP and lamins (Kaufmann, 1989;
Ucker et al., 1992
 
a
 
; Lazebnik et al., 1994, 1995); chromatin
condensation; and nuclear fragmentation into apoptotic
bodies (Lazebnik et al., 1993). This entire program of apop-
totic events is inhibited in vitro
 
 
 
by caspase inhibitors (La-
zebnik et al., 1994) or millimolar concentrations of Zn
 
2
 
1
 
(Lazebnik et al., 1993) just as in intact cells. Although nu-
clei are used as the substrate in these studies, the extracts
themselves are derived from the cytoplasm of the DU249
cells (Lazebnik et al., 1993), thus supporting the view that
cytoplasmic factors and events have an essential role in the
apoptotic pathway (Jacobson et al., 1994; Schulze-Osthoff
et al., 1994; Nakajima et al., 1995; Martin et al., 1996; Kroe-
mer, 1997).
The aim of the present study was to extend this ap-
proach by preparing extracts from cells at various stages of
the apoptotic pathway to further evaluate caspase involve-
ment in nuclear disassembly. Interestingly, extracts pre-
pared from morphologically normal cells in the latent
phase (S/M extracts) and those prepared from frankly
apoptotic cells (execution phase extracts) induced similar
apoptotic events in exogenous nuclei but exhibited funda-
mental biochemical differences. In particular, apoptotic
events in the S/M extracts were abolished by caspase in-
hibitors as previously reported (Lazebnik et al., 1994),
whereas the same events in execution phase extracts were
not. Further examination revealed that execution phase
extracts contain at least two caspase-activated factors re-
quired for nuclear disassembly, one of which appears to be
the nuclease CAD. These experiments not only support
the view that caspases act in an executive role in nuclear
apoptosis by activating downstream factors that disassem-
ble nuclei but also suggest that activation of the down-
stream factors (rather than the caspases) accompanies the
transition between the latent and execution phases of apop-
tosis.
 
Materials and Methods
 
Cell Treatment and Preparation of Extracts
 
Chicken DU249 cells were presynchronized in S phase with aphidicolin
for 12 h, released from the block for 6 h, and synchronized in mitosis with
nocodazole for 3 h as described previously (Wood and Earnshaw, 1990;
Lazebnik et al., 1993). DU249 cells start to undergo apoptosis asynchro-
nously during and after the aphidicolin treatment, presumably as a result
of the cell cycle disruption. Execution phase (E/X) extracts were prepared
from the floating cells (mostly apoptotic) obtained from the flasks just be-
fore the addition of nocodazole. S/M extracts were prepared from floating
cells (
 
.
 
60% mitotic) obtained from the same flasks by selective detach-
ment after the nocodazole treatment. After harvesting of cells for S/M ex-
tract production, cells for the preparation of condemned phase (C/D) ex-
tracts were obtained from the attached (interphase) cells by rinsing the
same flasks with PBS-EDTA and trypsinization. Large scale “roller S/M”
extract was prepared as described above for S/M extract except that cells
were grown in roller bottles.
In each case, the cells were then washed with KPM buffer (50 mM
Pipes-KOH,
 
 
 
pH 7.0, 50 mM KCl, 10 mM EGTA, 2 mM MgCl
 
2
 
, 20 
 
m
 
M cy-
tochalasin B [Sigma Chemical Co., St. Louis, MO], 1 mM DTT, 0.1 mM
PMSF, 1 
 
m
 
g/ml each chymostatin, leupeptin, antipain, pepstatin A)
(Wood and Earnshaw, 1990) and centrifuged in a small glass Dounce ho-
mogenizer. The cells were subjected to several cycles of freezing and
thawing and further disrupted by grinding during each thawing cycle. The
cell lysate was then centrifuged at 139,000 
 
g
 
 for 2 h, yielding clear cytosolic
extracts. Protein concentration of each extract was measured by the Brad-
ford assay (Bradford, 1976). Extract concentrations ranged between 12
and 18 mg/ml.
 
Time Course of Caspase Activation
 
DU249 cells were subjected to the synchrony procedure used in prepara-
tion of S/M extracts. At the indicated times (0, 5, 10, 15, and 20 h) after the
addition of aphidicolin, both floating and attached cells were harvested
from two T150 flasks (the former by shake-off, the latter by trypsiniza-
tion). Cells were washed with MDB buffer, and the number of cells in
each sample was counted using a hemacytometer. The ratio of interphase,
mitotic, and apoptotic cells in each sample was determined by examina-
tion of the nuclear morphology after cells (
 
n
 
 
 
. 
 
400 for each time point)
were fixed in methanol/acetic acid (3:1) and stained with 0.5 
 
m
 
g/ml 4,6-dia-
midino-2-phenylindole (DAPI; Calbiochem, La Jolla, CA). Cells were
lysed by the freeze/thaw/grinding protocol described above. Lysates (the
supernatants after centrifugation at 13,000 
 
g
 
 for 15 min at 4
 
8
 
C) were affin-
ity labeled with z-EK(biotin)D-aomk as described below.
 
Fractionation of S/M Extracts with
Heparin–Agarose Resin
 
Roller S/M extract (typically 7 mg of protein) prepared in KPM buffer
containing 60 mM KCl was mixed with 360 
 
m
 
l of heparin–agarose resin
(HiTrapHeparin; Pharmacia Biotech, Piscataway, NJ), which was pre-
equilibrated with KPM buffer. This mixture was rotated at 4
 
8
 
C for 1 h and
centrifuged in a microcentrifuge at 5,000 rpm for 5 min, and the superna-
tant was recovered (fraction 1; data not shown). Three cycles of absorp-
tion with heparin–agarose were needed to completely absorb all DNase
activities from S/M extracts. After extensive washing of the resin with KPM
buffer containing 60 mM KCl, bound proteins were eluted first with 450 
 
m
 
l
of KPM containing 0.2 M KCl (fraction 2), and subsequently with 450 
 
m
 
l 
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of KPM containing 0.6 M KCl (fraction 3). The eluted fractions were de-
salted and concentrated to 4–8 mg/ml protein by centrifugation using Ul-
trafree-0.5 filters (5K cut; Millipore, Bedford, MA).
 
In Vitro Apoptosis Reaction
 
Apoptotic and control extracts were preincubated at 37
 
8
 
C for 15 min with
100 
 
m
 
M caspase inhibitors (YVAD-cmk or DEVD-fmk) or diluent. HeLa
nuclei prepared as previously described (Wood and Earnshaw, 1990; La-
zebnik et al., 1993) were then added (up to 1.0 
 
3 
 
10
 
6
 
 nuclei/10 
 
m
 
l of ex-
tract) and incubated at 37
 
8
 
C for up to 2 h in the presence of an ATP regen-
eration system (Wood and Earnshaw, 1990; Lazebnik et al., 1993). Nuclei
were either stained with DAPI to observe chromatin condensation, solu-
bilized in SDS–sample buffer for analysis of protein cleavage, or lysed for
analysis of DNA ladder formation.
 
Caspase Labeling and Fluorogenic Assays
 
Labeling. 
 
Stock solutions (10 mM in DMSO) of caspase inhibitors
(YVAD-cmk or DEVD-fmk from Calbiochem) were diluted immediately
before use with MDB buffer (Wood and Earnshaw, 1990). Extracts were
preincubated at 37
 
8
 
C for 15 min with 100 
 
m
 
M YVAD-cmk or DEVD-fmk
or diluent. After Z-EK(bio)D-aomk (Martins et al., 1997
 
a
 
) was added to a
final concentration of 1 
 
m
 
M from a 100
 
3 
 
stock solution in DMSO, ex-
tracts were incubated at 37
 
8
 
C for 15 min. Labeled proteins were subjected
to conventional 16% SDS-PAGE (Laemmli, 1970), transferred to nitro-
cellulose membrane, probed with peroxidase-coupled streptavidin, and vi-
sualized by ECL (Amersham Corp., Arlington Heights, IL).
 
Fluorogenic Assays. 
 
DEVD-AFC cleavage activity was determined by a
slight modification of previously described methods (Martins et al.,
1997
 
a
 
). Extracts were preincubated with caspase inhibitors or diluent for
15 min at 37
 
8
 
C. Samples containing 20–30 
 
m
 
g of various fractions or 25 
 
m
 
g
of cytosolic protein (estimated by the Bradford assay) from etoposide-
treated K562 leukemia cells (a positive control) were diluted to 50 
 
m
 
l with
buffer A (25 mM Hepes, pH 7.5, 5 mM MgCl
 
2
 
, 5 mM EDTA, 1 mM EGTA
supplemented immediately before use with 1 mM PMSF, 1 mM DTT, 10
 
m
 
g/ml pepstatin A, and 10 
 
m
 
g/ml leupeptin), mixed with 225 
 
m
 
l freshly pre-
pared buffer B (25 mM Hepes, pH 7.5, 0.1% [wt/vol] CHAPS, 10 mM
DTT, 100 U/ml aprotinin, 1 mM PMSF) containing 100 
 
m
 
M DEVD-AFC
(Enzyme System Products, Dublin, CA), and incubated for 4 h at 37
 
8
 
C.
Reactions were terminated by addition of 1.225 ml ice-cold buffer B. Fluo-
rescence was measured in a Sequoia-Turner spectrofluorometer using an
excitation wavelength of 360 nm and emission wavelength of 475 nm. After
subtraction of fluorescence in blank samples (lacking protein), amounts of
the liberated fluorophore were determined by comparison to a standard
curve containing 0–1,500 pmol of 7-amino-4-trifluoromethylcoumarin.
Control experiments indicated that product release was linear with re-
spect to incubation time and extract protein under the conditions used.
 
Protein and DNA Gel Electrophoresis
 
PARP and Lamin Cleavage. 
 
After HeLa nuclei (5 
 
3 
 
10
 
5
 
 per loading) were
incubated in extract for 2 h at 37
 
8
 
C, the reaction was stopped by the addi-
tion of sample buffer. Samples were boiled at 95
 
8
 
C for 5 min, sonicated
briefly, subjected to 10% conventional SDS-PAGE (Laemmli, 1970;
Wood and Earnshaw, 1990; Lazebnik et al., 1993), and transferred to ni-
trocellulose. PARP and its 89-kD cleavage product were detected with the
C-2-10 monoclonal antibody (Lamarre et al., 1988). Lamins A/C and their
cleavage product were detected with a rabbit polyclonal antibody recog-
nizing the NH
 
2
 
 terminus of the protein (gift of Larry Gerace). Bound anti-
body was detected by ECL.
 
DNA Ladder Formation. 
 
HeLa nuclei (5 
 
3 
 
10
 
5
 
 per loading) were incu-
bated for 1–2 h in extract, centrifuged, and lysed in DNA lysis buffer (50
mM Tris-HCl, pH 8.0, 10 mM EDTA, 0.5% Sarcosyl, 0.5 mg/ml protein-
ase K) at 50
 
8
 
C for 1 h. DNA was treated with RNase at 50
 
8
 
C for 1 h, phe-
nol/chloroform extracted, ethanol-precipitated overnight at 
 
2
 
70
 
8
 
C, resus-
pended in TE, and loaded onto 1% agarose gels containing 0.5 
 
m
 
g/ml
ethidium bromide.
 
Plasmid DNA Digestion Assay. 
 
Extracts (18–36 
 
m
 
g protein in 10 
 
m
 
l of
KPM buffer) supplemented with an ATP regeneration system (Wood and
Earnshaw, 1990) and 100 
 
m
 
M DEVD-fmk (or diluent) were incubated at
37
 
8
 
C for 15 min. After addition of 160 ng purified glutathione-S-trans-
ferase–ICAD (GST-ICAD) (Sakahira et al., 1998), incubation was contin-
ued for an additional 10 min at 37
 
8
 
C. Upon addition of substrate (pBlue-
script, 1.2 
 
m
 
g), incubation was continued for 30 min at 37
 
8
 
C. DNA
extraction and electrophoresis were then performed as above. The results
of the preincubation assay (Fig. 5) were best seen by Southern blotting.
DNA agarose gels were denatured for 30 min with denaturing buffer (1.5
M NaCl, 0.5 M NaOH), neutralized for 30 min with neutralizing buffer
(0.5 M Tris-HCl, pH 7.5, 1.5 M NaCl, 1 mM EDTA), and transferred to
nylon membrane (Hybond-N; Amersham Corp.) with 20
 
3
 
 SSC buffer.
The nylon membrane was UV cross-linked and hybridized (Church and
Gilbert, 1984) with a pBluescript probe that was labeled with 
 
32
 
P using the
megaprimer system (Amersham Corp.). The film was exposed for 1 h at
 
2
 
80
 
8
 
C with an intensifying screen.
 
Pulsed-Field Gel Electrophoresis. 
 
HeLa nuclei (5 
 
3 
 
10
 
5
 
) were incubated
with each fraction (10 
 
m
 
l) for the specified time and embedded in 1.5%
low melting agarose (Sea Plaque GTG agarose, FMK). Gel blocks were
soaked in nuclei lysis buffer (10 mM Tris-HCl, pH 9.5, 500 mM EDTA, 1
mg/ml proteinase K, 1% sarkosyl) for 20 h at 50
 
8
 
C and then stored in TE
buffer at 4
 
8
 
C. Blocks were transferred into the wells of an agarose gel and
sealed in place by the addition of a small volume of agarose. Contour-
clamped homogeneous (CHEF) electrophoresis was performed using a
CHEF system purchased from Bio-Rad Laboratories Ltd. (Watford, En-
gland) with a model 200/2.0 power supply and a Pulsewave 760 switcher.
Horizontal gels (1% agarose; Sigma Chemical Co.) were run at 14
 
8
 
C at
200 V for 20 h with a pulse ramp of 4–40 s and stained with ethidium bro-
mide.
 
Electron Microscopy. 
 
Isolated HeLa cell nuclei incubated in extract or
MDB buffer were centrifuged, washed with MDB buffer, placed on adhe-
sion slides (Marienfeld) for 5 min, and fixed for 30 min with 2% glutaral-
dehyde in Dulbecco’s PBS, pH 7.4. After fixation the nuclei were washed
in 0.1 M cacodylate buffer, and postfixed with 4% OsO
 
4 
 
in 0.1 M sodium
cacodylate, pH 7.4, for 30 min. Prestaining was done with 3% uranyl ace-
tate in H
 
2
 
O for 1 h. The nuclei were dehydrated in ethanol (30–100%) and
embedded in Araldite resin (Agar). Gold sections were cut with a Rei-
chert (Vienna, Austria) microtome and placed on copper grids. Images
were photographed on an electron microscope (model CM100 Biotwin;
Philips Electron Optics, Mahwah, NJ).
 
Expression and Purification of Double
Mutant His
 
6
 
-ICAD
 
The method used for mutation was the PCR-based megaprimer strategy
(Seraphin and Kandels-Lewis, 1996). Primer 1 (T7 primer), primer 2 (5
 
9
 
-
GCCCTGCTCTCAGGCTCATC-3
 
9
 
), and primer 3 (5
 
9
 
-CAGCTCTG-
CACATGGGATGTC-3
 
9
 
) were used to generate the DEPD
 
117
 
E mutation
in the ICAD cDNA in pBluescript. Primer 4 (5
 
9
 
-CTGCTGTCAGAA-
GAGGACCTC-3
 
9
 
), primer 5 (5
 
9
 
-GCCGACGCCTGTCTCAACTGC-
3
 
9
 
), and primer 6 (T3 primer) were used to generate the DAVD
 
224
 
E muta-
tion in ICAD. Each single mutant was digested with Eco47III (New
England Biolabs, Hitchin, UK) and XbaI (New England Biolabs) and
then ligated to generate double mutant ICAD in pBluescript. This double
mutant ICAD was digested with SpeI, blunt-ended with T4 DNA poly-
merase (New England Biolabs) plus 100 
 
m
 
M dNTPs, and digested with
KpnI (New England Biolabs). The resulting fragment was ligated into
pRSET B (Invitrogen, Carlsbad, CA) that had been digested with HindIII,
blunt-ended with T4 DNA polymerase, and digested with KpnI. Double
mutant ICAD in pRSETB was transformed into 
 
Escherichia coli
 
 BL21
(DE3)Lys S cells. Transformed cells were grown to OD
 
600
 
 
 
5 
 
0.5–0.7, and
protein expression was induced with IPTG (1 mM) for 3–4 h. Cells were
collected by centrifugation at 5,000 
 
g
 
 for 10 min and frozen at 
 
2
 
80
 
8
 
C. The
cell pellet was thawed on ice for 15 min and resuspended in lysis buffer (50
mM NaH
 
2
 
PO
 
4
 
 pH 7.5, 300 mM NaCl, 10 mM imidazole). Lysozyme was
added to 1 mg/ml, and the suspension was incubated on ice for 30 min,
sonicated on ice until 80% of the cells were disrupted, and then centrifuged
at 4,000 
 
g
 
 for 20 min at 4
 
8
 
C. The supernatant was incubated on a rotating
mixer for 1 h at 4
 
8
 
C with 0.5 ml of Ni-agarose (Qiagen, Chatsworth, CA)
that had been preequilibrated with lysis buffer. The resin was then loaded
onto a polyprep chromatography column (Bio-Rad Laboratories) and
washed twice with 4 ml of wash buffer (50 mM NaH
 
2
 
PO
 
4
 
 pH 7.5, 300 mM
NaCl, 20 mM imidazole). Protein was eluted with 2 ml of elution buffer
(50 mM NaH
 
2
 
PO
 
4
 
 pH 7.5, 300 mM NaCl, 250 mM imidazole). All samples
were subjected to SDS-PAGE and examined by Coomassie blue staining.
The eluted protein was dialyzed for at least 3 h against two changes of
CAD buffer (10 mM Hepes, pH 7.4, 50 mM NaCl, 5 mM EGTA, 2 mM
MgCl
 
2
 
,
 
 
 
1 mM DTT), aliquoted, and frozen in N
 
2
 
(l).
 
Expression and Purification of His
 
6
 
-ICAD/CAD
 
To express active CAD in 
 
E
 
.
 
 coli
 
, we constructed a bicistronic expression
vector in which His
 
6
 
-ICAD was expressed upstream of CAD. In addition 
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to the NH
 
2
 
-terminal histidine tag, the ICAD open reading frame was engi-
neered to change the stop codon to TAA and to insert a Shine-Delgarno
sequence (GGAAT) downstream of the stop codon. The wild-type ICAD
cDNA in pBluescript was digested with SpeI, blunt-ended with T4 DNA
polymerase, and digested with KpnI. The resulting fragment was ligated into
pRSET B that had been digested with HindIII, blunt-ended with T4 DNA
polymerase, and digested with KpnI. The coding region of the CAD cDNA
was extracted from the full-length CAD cDNA in pBluescript by PCR using
Vent polymerase (New England Biolabs) with primer 7 (5
 
9
 
-GGAATTCAT-
GTGCGCGGTGCTCCG-3
 
9) and primer 8 (59-GCGAAGCTTTCAC-
TAGCGCTTCCGAG-39). The PCR product was digested with EcoRI
and HindIII, and the resulting fragment was ligated into pBluescript.
To create the COOH terminus of ICAD (from the BsmI site at nucle-
otide 909) engineering in a TAA stop codon and Shine-Delgarno se-
quence, primer 9 (59-GGAAGATCTGCATTCACTCAGGAATC-39)
and primer 10 (59-GGAATTCCTCCTTACGAGGAGTCTCGTTTG-39)
were used with Vent polymerase. The PCR product was digested with
BglII (New England Biolabs) and EcoRI and ligated into pRSETB that
had been digested with BglII and EcoRI. The CAD coding sequence in
pBluescript was digested with EcoRI and HindIII and ligated into pRSET
B containing the newly modified COOH terminus of ICAD with the
Shine-Delgarno sequence. This intermediate was then digested with NheI
and BsmI, and into it was inserted the His-tagged NH2-terminal portion of
ICAD, obtained from ICAD in pRSETB that had likewise been digested
with NheI and BsmI. This bicistronic vector His6-ICAD/CAD in pRSET
B was transformed into E. coli BL21 (DE3)Lys S cells. Protein was ex-
pressed and purified by nickel chelate chromatography as described above
for double mutant ICAD. The dialyzed ICAD/CAD protein was frozen in
N2(l) either directly or following addition of glycerol to 40%.
In Vitro Apoptosis with Purified CAD
50-ml reactions contained various combinations of the following reagents
added sequentially (see legend to Fig. 6): 10 ml ICAD/CAD protein
(stored in CAD buffer plus 40% glycerol), 5 ml caspase-3, an ATP regen-
eration system (final concentration 0.8 mM ATP, 4.5 mM creatine phos-
phate, 22.5 mg/ml creatine kinase), DEVD-fmk (final concentration 300
mM), double mutant ICAD protein (2 mg), and CAD buffer as needed to
make up the final volume. ICAD/CAD complexes were preincubated
with caspase-3 at room temperature (z258C) for 30 min to cleave wild-type
ICAD and release active CAD. At the end of this preincubation, diluent,
DEVD-fmk, or double mutant ICAD were added (defined as t 5 0), and
the mixture was divided into three aliquots to assay various apoptotic
events. To examine ICAD cleavage during the preincubation, a 10-ml ali-
quot was mixed with sample buffer, boiled, resolved by SDS-PAGE,
transferred to nitrocellulose membranes, and probed with ICAD antibody
(Samejima and Earnshaw, 1998), which was detected by ECL (Amersham
Corp.). To assay CAD activity against a plasmid DNA substrate, a 6-ml al-
iquot was supplemented with 0.35 mg pBluescript, BSA (final concentra-
tion 1 mg/ml), and 4 ml of CAD buffer. This mixture was further incubated
at 378C for 30 min, extracted with phenol-chloroform, and analyzed on a
1% agarose gel containing ethidium bromide. To examine the ability of
the active CAD to induce apoptotic events, HeLa nuclei (1.3 3 106 per
sample) in 10 ml CAD buffer were combined with the remaining 34 ml and
incubated at 378C for 2 h. At the end of this incubation, 1 ml of the reac-
tion mixture was stained with DAPI so that nuclear morphology could be
examined by fluorescence microscopy (.100 nuclei counted per slide).
The remaining HeLa nuclei in 43 ml of reaction mixture were centrifuged
and prepared for agarose gel electrophoresis as described above.
Results
Extracts from Three Different Stages of Apoptosis
The apoptotic pathway can be conceptually divided into at
least three stages (Fig. 1 A). Upon receipt of a proapop-
Figure 1.( A ) Diagram of apoptosis as a three
stage process, with the latent phase being sub-
divided into condemned and committed
stages. (B) The protocol used for harvesting
of samples for examination of caspase activa-
tion. (C) The cells harvested at each time
point were scored for their nuclear morphol-
ogy, based on DAPI staining. (D) Caspase ac-
tivity in whole cell lysates prepared from cells
harvested at various times points after the ad-
dition of aphidicolin to the culture (time in
hours shown at bottom). Left, attached cells;
right, floating cells. The left-most lane shows
the profile of active caspases in S/M extract.Samejima et al. Nuclear Apoptosis Downstream of Caspases 229
totic signal, cells enter a “condemned” stage: the death
program is initiated, but cells can be rescued by various
survival factors. Once cells pass a point of no return, they
are in the “committed” stage and can no longer be res-
cued. During both of these stages, preapoptotic cells ap-
pear morphologically normal. Eventually, committed cells
undergo an abrupt transition into apoptotic execution, a
period lasting from 5 min to 1 h, during which cellular dis-
assembly and death occur. It is not known where along this
pathway caspases are activated and at what point the
caspases activate other downstream factors that act during
disassembly of the cell.
We previously noted that active caspases could be de-
tected in extracts from etoposide-treated HL-60 cells sev-
eral hours before the bulk of the cells in the culture exhib-
ited an overtly apoptotic morphology (Martins et al.,
1997a). To study this phenomenon in greater detail, we
harvested chicken DU249 cells at various times after sub-
jecting cultures to a synchronization protocol (Fig. 1 B)
shown previously to induce an apoptotic response in this
cell line (Lazebnik et al., 1993). Floating cells obtained 10–
15 h after the addition of aphidicolin were largely (z 50%)
apoptotic and contained high levels of active caspases, as
detected by reactivity with the affinity-labeling reagent
z-EK(biotin)D-aomk (Martins et al., 1997a) (Fig. 1, C and
D). Floating cells harvested after a change of medium and
a 2-h treatment with nocodazole to induce a mitotic block
were predominantly (.60%) mitotic, with only 10–20% of
apoptotic cells. Despite the normal appearance of the vast
majority of these cells, extracts prepared from them also
contained high levels of active caspases. Cells that re-
mained attached throughout the protocol were almost en-
tirely in interphase, and extracts prepared from them
lacked caspases detectable with z-EK(biotin)D-aomk (Fig.
1 D, left), although low levels of caspase activity were de-
tectable when more sensitive assays were used (see be-
low).
The results of this experiment suggested that it might be
possible to use a similar protocol to prepare extracts se-
quentially from the same flasks of cells at different stages
of apoptosis (Fig. 2 A). C/D (condemned phase) extracts
were prepared from the morphologically normal attached
cells that did not enter mitosis or apoptosis during the syn-
chrony procedure. Previous studies have indicated that
these cells ultimately undergo apoptosis if left in culture
(Lazebnik et al., 1993). S/M (committed phase) extracts
Figure 2. Apoptotic extracts contain active caspases that are
functionally inactivated by specific inhibitors. (A) Protocol used
to prepare C/D, S/M, and E/X extracts. (B) Quantitative analysis
of DEVD-AFC cleavage activity in the various extracts. DEVD-
fmk treatment of S/M and E/X extracts reduces caspase activity
by at least 250- and 150-fold, respectively. Note the low but non-
zero level of caspase activity in the C/D extracts. Fr-3 (see Fig. 4)
has z8% the caspase activity seen in S/M extract. Treatment of
Fr-3 with DEVD-fmk further reduces this activity by $130-fold
relative to the S/M extract. (C) Active caspases were labeled with
zEK(biotin)D-aomk in S/M and E/X extracts. This labeling was
completely blocked by prior incubation of extracts with YVAD-
cmk and DEVD-fmk (both at 100 mM). (D) PARP and lamin
A/C cleavage by caspases in the cell-free extracts is abolished af-
ter caspase inactivation with YVAD-cmk and DEVD-fmk. Note
that low levels of caspases in the C/D extract cause some PARP
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(Lazebnik et al., 1993) were prepared from morphologi-
cally normal mitotic cells at the conclusion of the syn-
chrony procedure. Because these cells are destined to rap-
idly undergo apoptosis if left in culture (Lazebnik et al.,
1993), we postulate that S/M extracts reproduce events
from the committed stage of apoptosis. E/X (execution
phase) extracts were prepared from cells that were frankly
apoptotic after a 12-h exposure to aphidicolin followed by
a 6-h recovery period in medium. (Note that nonadherent
cells were discarded at the end of the aphidicolin treat-
ment, so these cells must have entered apoptosis during
the 6-h recovery period).
To examine the spectrum of active caspases during the
three stages of apoptosis, extracts were assayed for their
ability to cleave DEVD-AFC, for affinity labeling with
z-EK(bio)D-aomk (Martins et al., 1997a), and for the abil-
ity to cleave known caspase substrates in added nuclei.
Collectively, these assays detect all known caspases.
DEVD-AFC contains the preferred cleavage site of
caspases-3 and -7 (Talanian et al., 1997; Duan et al., 1996b)
but is also cleaved by caspases-1, -2, -4, -6, -8, and -10
(Fernandes-Alnemri et al., 1995a, 1996; Boldin et al., 1996;
Srinivasula et al., 1996; Talanian et al., 1997). z-EK(bio)D-
aomk covalently modifies all caspases tested to date (Mar-
tins et al., 1997a) and can detect over 30 active caspase
species in apoptotic human leukemia cells (Martins, L.M.,
and W.C. Earnshaw, unpublished observations). PARP is
a documented substrate of caspases-3, -7, -8, and -9
(Nicholson et al., 1995; Tewari et al., 1995; Fernandes-
Alnemri et al., 1995a,b; Duan et al., 1996b; Muzio et al.,
1996), while lamin A is a substrate of caspase-6 (Takahashi
et al., 1996). Application of these assays to C/D extracts
revealed low but detectable levels of active caspases (125-
fold less than S/M or E/X extracts in the DEVD-AFC as-
say; Fig. 2 B) and some ability to cleave PARP (Fig. 2 D,
lane C/D), but no evidence of z-EK(biotin)D-aomk label-
ing or lamin cleavage, suggesting that the latter assays are
less sensitive. In contrast, S/M and E/X extracts contained
high levels of active caspases that cleaved DEVD-AFC as
well as PARP and lamin A (Fig. 2, B and D), and both had
a similar pattern of active caspases after affinity-labeling
with z-EK(bio)D-aomk (Fig. 2 C). These correspond pri-
marily to active forms of caspases-3 and -6 (Martins et al.,
1997a; Faleiro et al., 1997). All caspase activity detectable
in these assays was quantitatively inactivated by treatment
with YVAD-cmk (Fig. 2, C and D) or DEVD-fmk (Fig. 2,
B–D).
Differences in Dependence of S/M and E/X Extracts on 
Ongoing Caspase Activity
C/D extracts were unable to induce internucleosomal
DNA fragmentation and apoptotic morphological changes
in exogenous nuclei (Fig. 3, A and B). In contrast, S/M and
Figure 3. Caspase inhibitors block apoptosis in S/M but not E/X
extracts. (A) Inhibition of caspases blocks nuclease activity in S/M
extracts but not E/X extracts. As expected, C/D extracts lack de-
tectable nuclease activity. Experiments shown in Fig. 8 confirm
that the nuclease activity is inhibitable by the specific CAD inhib-
itor ICAD/DFF45 (Enari et al., 1995b; Liu et al., 1997). Lane B,
buffer control. (B) Inhibition of caspases abolishes morphologi-
cal apoptosis in vitro in S/M extracts but not execution phase ex-
tracts. Nuclei shown in B were selected at random. (C) Morpho-
logical changes characteristic of apoptosis occur in E/X extracts
independently of caspase activity: confirmation of apoptotic mor-
phology by electron microscopy. Arrows indicate regions of con-
densed chromatin. Bars: (B) 5 mm; (C) 1 mm.Samejima et al. Nuclear Apoptosis Downstream of Caspases 231
E/X extracts induced hallmark biochemical and morpho-
logical changes of apoptosis in added nuclei. Further stud-
ies focused on these latter two extracts.
Despite the similarities of the S/M and E/X extracts in
terms of caspase activity (Fig. 2) and effects on exogenous
nuclei (Fig. 3, A and B), the two extracts displayed strik-
ingly different properties after inhibition of the endoge-
nous caspase activity. Pretreatment of S/M extracts with
DEVD-fmk or YVAD-cmk before addition of nuclei not
only inhibited caspase activity (Fig. 2, B–D) but also com-
pletely abolished their ability to produce internucleosomal
DNA fragmentation (Fig. 3 A) and induce morphological
apoptotic changes (Fig. 3 B). In striking contrast, E/X ex-
tracts that had been pretreated with caspase inhibitors
continued to strongly induce internucleosomal DNA deg-
radation (Fig. 3 A), chromatin condensation, and fragmen-
tation of added nuclei (shown both by light and electron
microscopy; Fig. 3, B and C) despite a lack of detectable
caspase activity (Fig. 2, B–D).
Fractionation of Active Extracts
Further evidence for the ability of extracts to induce nu-
clear apoptotic events in the absence of caspase activity
Figure 4. A fraction rich in
endogenous caspases fails to
induce apoptotic events in
added nuclei. (A) Protocol
used to prepare fractions 1–3
by heparin–agarose chroma-
tography of roller S/M ex-
tract. (B) Active caspases
were labeled with zEK(bi-
otin)D-aomk in roller S/M
extract and fraction 2, but
could not be detected in Fr-3.
The bands in the upper por-
tion of the gel are cellular
proteins that bind to the
streptavidin probe. (C) PARP
and lamin A are efficiently
cleaved by roller S/M extract
and by Fr-2. Fr-3 has low lev-
els of PARP cleavage activity
that are abolished by pre-
treatment with DEVD-fmk.
(D) Pulsed field gel electro-
phoresis. High molecular
weight DNA fragments were
produced in HeLa nuclei in-
cubated in roller S/M extracts
and Fr-3 (caspase-deficient),
but not in nuclei incubated in
buffer or Fr-2, which contains
high levels of active caspases.
Lane M, DNA markers (sizes
shown in kilobase pairs). (E)
Conventional agarose gel
electrophoresis. An oligonu-
cleosomal DNA ladder is
formed in nuclei incubated in
roller S/M extracts and Fr-3,
but not in nuclei incubated in
buffer or Fr-2. Lane M, DNA
markers (sizes shown in base
pairs). (F) Fr-3 induces very
strong morphological apop-
tosis even when all detectable
caspase activity is abolished
by pretreatment with DEVD-
fmk. In contrast, Fr-2, which
has a distribution and con-
centration of caspases essen-
tially identical to S/M extract,
does not induce morphologi-
cal apoptosis in HeLa nuclei.The Journal of Cell Biology, Volume 143, 1998 232
was obtained through biochemical fractionation of large-
scale roller S/M extracts prepared using cells growing in
roller bottles. These extracts appeared to functionally re-
semble a mixture of S/M and E/X extracts (i.e., were only
partly inhibited by DEVD-fmk or YVAD-cmk). We be-
lieve that this is because a much higher percentage of apop-
totic cells was present among the committed phase cells at
the time of harvest. When roller S/M extracts were frac-
tionated on heparin agarose (Fig. 4 A), proteins eluted
from the column at 0.2 M KCl (fraction 2 [Fr-2]) included
many of the active endogenous caspases, as shown by their
ability to cleave the peptide substrate DEVD-AFC (Fig. 2
B), by activity labeling with z-EK(biotin)D-aomk (Fig. 4
B), and by cleavage of PARP and lamin A (Fig. 4 C). Fac-
tors eluted from the column at 0.6 M KCl (fraction 3
[Fr-3]) were substantially depleted of caspases, and this
fraction resembled C/D extracts in several regards. DEVD-
AFC cleavage activity in Fr-3 was reduced 13-fold relative
to roller S/M extract (Fig. 2 B), and only trace levels of
PARP cleavage activity were detected (compare Fig. 4 C,
lanes Fr-3, with Fig. 2 D, lane C/D). Both zEK(biotin)D-
aomk binding activity and lamin A cleaving activity were
undetectable in Fr-3 (Fig. 4, B and C).
Although fraction 2 contained high levels of endoge-
nous caspase activity, it was unable to trigger either inter-
nucleosomal DNA fragmentation or morphological apop-
tosis in added nuclei. In contrast, fraction 3 was a more
potent inducer of apoptosis than the starting roller S/M ex-
tract, inducing both high molecular weight and oligonu-
cleosomal DNA fragmentation (Fig. 4, D and E) as well as
morphological apoptosis in substrate nuclei (Fig. 4 F). This
activity was not due to the low levels of residual caspases
present in fraction 3. Pretreatment with DEVD-fmk,
which abolished all detectable caspase activity (Fig. 2 B),
had no effect on the ability of fraction 3 to induce DNA
fragmentation (not shown) or apoptotic morphology in
added nuclei (Fig. 4 F). Thus, a column fraction rich in en-
dogenous apoptotic caspases (Fr-2) was unable to induce
morphological apoptosis in isolated nuclei, while a second
fraction prepared on the same column from the same ex-
tract (Fr-3) strongly induced apoptotic events despite be-
ing severely depleted or devoid (after inhibitor treatment)
of detectable caspase activity.
Comparison of CAD Activation in S/M and
E/X Extracts
Because the results presented in Figs. 2–4 suggest that the
program of nuclear disassembly—one of the distinguishing
features of apoptotic cell death under physiological condi-
tions (Wyllie et al., 1980)—is initiated by caspase activity
Figure 5. Differences in the activity of the CAD-like nuclease in
S/M and E/X extracts. (A) CAD-like nuclease in S/M extracts is
sensitive to DEVD-fmk, whereas that in E/X extracts is not. Apop-
totic extracts cleave a plasmid substrate at 378C (lanes 1 and 4).
The nuclease responsible is inhibited by purified murine GST-
ICAD (lanes 2 and 5) and therefore is functionally related to
murine CAD (Enari et al., 1998). In S/M extracts, but not E/X
extracts, the nuclease is abolished by addition of DEVD-fmk
together with the plasmid DNA (lanes 3 and 6). (B) Diagram of
experimental protocol designed to test whether the CAD-like en-
zyme is active in both S/M and E/X extracts before the incubation
with DNA. (C) In S/M extracts, the CAD-like activity increases
during preincubation of the extract at 308C before addition of the
plasmid DNA (lanes 1–5). This activity is now insensitive to the
addition of DEVD-fmk at the time of plasmid addition (lanes 19–
59). Bracket labeled “Frags” indicates the products of caspase
cleavage. The DNA cleavage activity in lane 19 may arise from
some limited activation of CAD before all caspases were inhib-
ited since DNA and DEVD-fmk were added at the same time.
(D) In contrast, preincubation has no effect on the cleavage of
plasmid substrate by E/X extracts (lanes 1–5), which is likewise
resistant to inhibition with DEVD-fmk (lanes 19–59). Lane D,
added plasmid DNA alone. Bracket labeled “Frags” indicates the
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but does not require the ongoing participation of caspases
for its successful execution, we next turned our attention
to caspase-activated downstream activities that might par-
ticipate in nuclear disassembly. One of these activities is
CAD/CPAN, the recently identified caspase-activated
deoxyribonuclease identified in murine and human cells
undergoing apoptosis (Enari et al., 1998; Halenbeck et al.,
1998). Both S/M and E/X extracts contain an endogenous
DNase activity that degrades added plasmid DNA (Fig.
5 A, lanes 1 and 4). Addition of 160 ng of murine ICAD
to the extracts abolished this DNase activity (lanes 2 and
5), indicating that this activity is functionally homologous
to CAD.
Even though CAD-like activity could be inhibited by
ICAD in both S/M and E/X extracts, this activity appeared
to be regulated differently in the two extracts. DEVD-fmk
pretreatment abolished CAD-like activity in S/M extracts
(Fig. 5 A, lanes 1 and 3) but had no effect on CAD activity
in E/X extracts (Fig. 5 A, lanes 4 and 6). There are at least
two potential explanations for this difference. First, active
CAD might be unstable in S/M extracts and might there-
fore require a constant source of caspase activity to con-
tinue to generate active enzyme from CAD/ICAD com-
plexes. Second, despite the presence of high levels of
endogenous caspases in S/M extracts, the CAD in these
extracts might initially be largely in the form of inactive
CAD/ICAD complexes. Active CAD might be released
from these complexes by caspase activity during the incu-
Figure 6. Bacterially expressed CAD is ca-
pable of inducing apoptotic morphology in
added nuclei in the absence of apoptotic
extract. (A) Diagram of the experimental
protocol. After CAD was activated during
a preincubation with purified caspase-3 at
258C, substrates were added and incubated
for various times with the active enzyme at
378C. (B) Effects of various incubations on
CAD nuclease activity using either a puri-
fied plasmid substrate (pBluescript, upper
panels) or added nuclei (lower panels). The
morphology of the nuclei in these same in-
cubations is shown in C, where the panel
numbers refer to lanes in B. Buffer and
caspase-3 do not possess nuclease activity
or induce apoptotic morphology in added
nuclei (lanes and panels 2 and 3). Preincu-
bation of CAD alone induces nuclease ac-
tivity and apoptotic morphology (lane and
panel 4), presumably because of the pres-
ence of a contaminating protease. ICAD is
cleaved during this preincubation (data not
shown). This spontaneous activation of
CAD is not observed if noncleavable
ICAD is present from the start of the pre-
incubation (lane and panel 5). Preincuba-
tion of CAD with caspase-3 induces nu-
clease activity and apoptotic morphology
(lane and panel 6). This activity is not ob-
served if noncleavable ICAD is present ei-
ther from the start of the preincubation, or
if it is added at the end of the preincuba-
tion together with the substrate nuclei
(lanes and panels 7 and 8). Addition of
DEVD-fmk to the preincubation blocks
CAD activation but has no effect on nu-
clease activity or induction of apoptotic
morphology if added once the preincuba-
tion is complete (lanes and panels 9 and
10). The induction of apoptotic morphol-
ogy by CAD in the presence of DEVD-
fmk was slightly, but reproducibly, reduced
(panel 10). These results demonstrate that
CAD can induce nuclear apoptosis in the
absence of caspase-3 activity. I and II at the
right of B indicate the migration of form I
(supercoiled) and form II (nicked circular)
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bation with DNA substrates.
To distinguish between these possibilities, we preincu-
bated S/M and E/X extracts at 308C for various times to
allow cleavage of endogenous ICAD by endogenous
caspases before adding DNA in the presence or absence of
DEVD-fmk (see the experimental protocol in Fig. 5 B).
This experiment indicated that CAD activity was initially
low in S/M extracts but increased gradually with incuba-
tion at 308C (Fig. 5 C, lanes 1–5). Once activated, CAD
was stable in the presence of DEVD-fmk (lanes 19–59). In
contrast, CAD was fully active at all times in E/X extracts
in the presence and absence of DEVD-fmk (Fig. 5 D).
Collectively, these results indicate that CAD is present but
inactive in extracts prepared from committed stage cells
and is activated in equivalent extracts prepared from exe-
cution phase cells. In addition, this result confirms that the
apoptotic activities present in S/M extracts are not due
solely to the presence of low levels of contaminating apop-
totic cells since these cells would be expected to have high
levels of active CAD.
CAD Alone Is Also Capable of Inducing Apoptotic 
Morphology in Added Nuclei
Collectively, the results presented in Figs. 3 and 5 suggest
that CAD might be a major factor that acts downstream of
caspases to induce changes in nuclear structure during
apoptotic execution. To examine this possibility in greater
detail, we exposed isolated nuclei to partly purified cloned
murine CAD. Active CAD was expressed in E. coli using
a bicistronic vector, which ensured that the CAD was
translated in the presence of an excess of ICAD (Enari et
al., 1998). The resulting CAD/ICAD complex was purified
by nickel chelate chromatography and then tested for ac-
tivity against plasmid and nuclear substrates according to
the experimental protocol shown in Fig. 6 A. Results ob-
tained with the plasmid substrate are shown in Fig. 6 B.
The CAD/ICAD complex purified from E. coli became
activated after a preincubation of 30 min at 258C either in
the absence (Fig. 6 B, lane 4) or presence (lane 6) of puri-
fied recombinant caspase-3. We assume that activation in
the absence of added caspase is due to the presence of
contaminating protease activity from the E. coli lysate.
Addition of double mutant ICAD (Sakahira et al., 1998)
at the start of the preincubation blocked CAD activation
in both the absence (lane 5) and presence (lane 7) of
caspase-3. Double mutant ICAD also blocked CAD activ-
ity if added at the end of the preincubation (lane 8). In
contrast, DEVD-fmk blocked CAD activation if added at
the start of the preincubation (lane 9) but had no effect if
added after cleavage of ICAD (lane 10).
The results obtained with the plasmid substrate were ex-
actly duplicated when we examined the ability of bacteri-
ally expressed CAD to induce DNA ladders and morpho-
logical changes in HeLa nuclei (Fig. 6, B and C). These
morphological changes were confirmed by electron mi-
croscopy, where condensed chromatin domains could be
seen to be closely apposed to the nuclear envelope (Fig.
7). When CAD was fully active, as detected using either
plasmid or nuclear substrates, the enzyme strongly in-
duced condensation of chromatin at the periphery of
added nuclei (Fig. 6, B and C, lanes and panels 4 and 6).
Higher levels of CAD induced the complete disassembly
of nuclei into apoptotic bodies (data not shown); however,
under these conditions nucleosomal ladders were no
longer seen (the DNA was fully degraded). Interestingly,
the addition of DEVD-fmk at time t 5 0 slightly inhibited
the morphological apoptosis (Fig. 6 C, panel 10), although
examples of fully apoptotic nuclei could still be seen. It is
important to note that caspase-3 alone was unable to in-
duce either DNA cleavage or apoptotic morphology in
added nuclei (lane and panel 3), consistent with the results
obtained with fraction 2 described above (Fig. 4 F).
Evidence for a Nuclear Disassembly Factor Distinct 
from CAD
To determine whether the CAD-like enzyme was the sole
Figure 7. Induction of apoptotic morphology in HeLa nuclei by
bacterially expressed CAD: analysis by electron microscopy. Nu-
clei treated with CAD—as shown in Fig. 6 B, lane and panel 6—
were embedded in plastic, thin sectioned, and examined in the
electron microscope. Regions of condensed chromatin are seen
to abut the nuclear envelope, and often protrude as though be-
ginning to bud outwards through the envelope. These images are
indistinguishable from previously published images of nuclei
treated with complete apoptotic extract (Lazebnik et al., 1993).
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activity downstream of caspases that drives nuclear disas-
sembly in these extracts, S/M and E/X extracts were
treated with ICAD before addition of exogenous nuclei.
Although addition of excess ICAD abolished production
of a nucleosomal ladder in nuclei added to S/M and E/X
extracts (Fig. 8 A, lanes 3–5 and 9–11), ICAD did not
block the ability of the extracts to induce chromatin con-
densation and nuclear fragmentation (Fig. 8 B, panels 3–5
and 9–11). The ability of the extracts to induce morpholog-
ical changes in the presence of ICAD was even more strik-
ing when the number of nuclei in the incubation was
reduced approximately fourfold (Fig. 8 C). These observa-
tions indicate that CAD-like activity is not essential for
apoptotic morphological changes in nuclei added to either
S/M or E/X extracts.
Interestingly, simultaneous inhibition of both CAD and
caspases did block the induction of apoptotic morphology
by E/X extracts (Fig. 8 B, panels 13 and 14; Fig. 8 C, d). As
indicated above, the caspase-rich column fraction Fr-2
lacked the ability to induce apoptotic morphological
changes in exogenous nuclei (Fig. 4 F). Moreover, addition
of purified caspases-3 and -6, the major active caspases in
Figure 8. Induction of apoptotic morphology
in cell extracts is not blocked by inhibition of
the CAD-like nuclease. (A) Induction of nu-
cleosomal ladders in added nuclei by S/M ex-
tract is sensitive to ICAD and DEVD-fmk
(lanes  3–8). Induction of nucleosomal ladders
in added nuclei by E/X extract is sensitive
only to ICAD (lanes 9–14). (DEVD-fmk
added: none, lanes 1–5 and 9–11; 100 mM,
lanes 6–8 and 12–14. ICAD added: none,
lanes  3,  6,  9, and 12; 160 ng, lanes 4, 7, 10, and
13; 320 ng, lanes 5, 8, 11, and 14.) (B) Both
S/M and E/X extracts can induce apoptotic
events under conditions where the CAD-like
nuclease is inhibited, provided that they re-
tain active caspases (panels 3–5 and 9–11).
E/X extracts, which normally induce apopto-
sis in the absence of caspase activity (panel
12), are unable to do so if ICAD is added
along with DEVD-fmk (panels 13 and 14).
Panel numbers refer to the gel lanes in A.
These images come from the same incuba-
tions shown in A. Time-lapse microscopy
analysis reveals that the C-shaped nuclei in
panels 3–5 and 9–11 are apoptotic nuclei in
which the nuclear envelope has ruptured after
collapse of the chromatin against the nuclear
periphery. (C) E/X extracts can fully induce
apoptotic morphology in the absence of
CAD-like activity, but this requires ongoing
caspase activity. In a different experiment
from that shown in A and B, the number of
nuclei per microliter of extract was reduced.
This gives a stronger induction of apoptotic
morphology (compare a with B, panel 9),
even when caspases (b) or CAD are inhibited
(c). Extracts produce a range of morphologies
in added nuclei. As in the experiment of A
and B, simultaneous inhibition of both CAD
and caspases abolishes morphological apopto-
sis in the extracts (d). These images were se-
lected from images taken at random.The Journal of Cell Biology, Volume 143, 1998 236
cytosol (Faleiro et al., 1997; Martins et al., 1997a) and nu-
clei (Martins et al., 1997a,b), failed to induce apoptotic
morphological changes in purified nuclei (data not shown;
identical to Fig. 6 C, panel 5). These observations appear
to rule out the possibility that caspases themselves are ca-
pable of inducing chromatin condensation by acting alone
on endogenous nuclear substrates. When coupled with
these results, the observation in Fig. 8 C, d, not only sug-
gests that there is a second chromatin condensation factor
present in the extracts but also raises the possibility that
ongoing caspase activity is required for activity of this factor.
Discussion
The experiments described above have led to a number of
novel observations: (a) It is possible to prepare cell-free
extracts specific for the latent and execution phases of
apoptosis. (b) These extracts, both of which contain active
caspases and induce apoptosis in substrate nuclei, exhibit
significant biochemical and functional differences that are
best explained if the transition from the latent to the exe-
cution phase of apoptosis is accompanied by a transition
from caspase-dependent to caspase-independent mecha-
nisms. (c) One aspect of this transition appears to involve
activation of a CAD-like nuclease, which is initially latent
in S/M extracts but is fully active in E/X extracts. (d) Mu-
rine CAD can induce an apoptotic morphology in isolated
nuclei. (e) In addition to CAD, apoptotic extracts contain
a second activity that can also induce apoptotic chromatin
condensation in added nuclei in the absence of DNA frag-
mentation. Each of these points is discussed in greater de-
tail below.
At present, there is no accepted biochemical marker to
rigorously distinguish between the condemned and com-
mitted stages of the latent phase. Here, we define latent
phase cells as those that have received a proapoptotic
stimulus but look morphologically normal. We then opera-
tionally define condemned cells as those that yield extracts
that lack significant caspase activity and do not induce
apoptosis in substrate nuclei. We operationally define
committed stage cells as those that yield extracts that con-
tain high levels of active caspases together with low levels
of active CAD and that strongly induce apoptosis in sub-
strate nuclei. As expected, these cells contain only low lev-
els of fragmented DNA themselves. Both of these latent
phase populations are readily distinguishable from overtly
apoptotic cells, which have detached from the substratum
and have sustained internucleosomal DNA degradation in
response to a proapoptotic stimulus. The various extracts
prepared from these three operationally defined cell pop-
ulations turned out to have remarkably distinct biochemi-
cal and functional characteristics.
The most significant difference was the finding that in-
duction of apoptotic events by committed stage extracts is
dependent on ongoing caspase activity, whereas induction
of apoptotic events by execution phase extracts is indepen-
dent of ongoing caspase activity. This observation is best
explained by a model in which caspases activate down-
stream factors that are responsible for condensation of the
chromatin during apoptosis. Such a model predicts that if
we were able to purify the active caspases from apoptotic
cells away from the downstream factors, then the caspases
on their own should be insufficient to induce apoptotic
events in substrate nuclei. To test this hypothesis, so-called
roller S/M extracts (large scale extracts functionally inter-
mediate between S/M and E/X extracts) were fractionated
on heparin–agarose. The fraction eluting with 0.2 M KCl
(Fr-2) appeared to not only encompass the entire range of
endogenous caspases activated during apoptosis in these
cells but was also highly active in the cleavage of caspase
target proteins. Nonetheless, this fraction was completely
unable to induce either DNA fragmentation or apoptotic
morphology in substrate nuclei. We have independently
shown that mixtures of purified caspases-3 and -6 are also
unable to induce apoptotic morphology in purified nuclei
(unpublished results). Thus, although recent experiments
indicate that caspase-3 is essential for nuclear apoptosis
(Jänicke et al., 1998; Woo et al., 1998), our experiments in-
dicate that this enzyme is likely to function by activating
downstream factors rather than directly disassembling the
nucleus itself.
A subsequent 0.6 M KCl wash of the same heparin–aga-
rose column yielded a fraction (Fr-3) that is rich in down-
stream apoptosis-promoting activities. Fr-3 strongly in-
duces DNA fragmentation and apoptotic morphology
despite the fact that it contains only very low levels of
caspases, similar to those seen in C/D extracts (which do
not induce apoptotic events in substrate nuclei). Further-
more, treatment of Fr-3 with caspase inhibitors (as well as
other protease inhibitors; see Materials and Methods) had
no effect on its apoptosis-promoting activity. Thus, this
fraction is a potential source of downstream factors acti-
vated during the apoptotic pathway.
One such downstream factor has recently been identi-
fied in murine cell extracts. CAD, the caspase-activated
DNase (Enari et al., 1998), interacts with an inhibitory
subunit termed ICAD/DFF45 (Sakahira et al., 1998; Liu et
al., 1997) to form an inactive complex that is thought to be
sequestered in the cytoplasm. Caspase cleavage of ICAD
is proposed to cause the release and subsequent nuclear
translocation of CAD, leading to digestion of the chroma-
tin (Sakahira et al., 1998). Here, we have shown that both
S/M and E/X extracts from chicken DU249 cells contain a
nuclease similar or identical to CAD, as defined by its abil-
ity to be quantitatively inhibited by exogenous purified
mouse ICAD. The fact that ICAD of mouse origin inhibits
the apoptotic nuclease in avian (chicken) cell extracts sug-
gests that the CAD nuclease and its interactions with
ICAD are widely conserved in phylogeny.
Because the same cohort of caspases is present and ac-
tive in the S/M and E/X extracts, the transition from the la-
tent to the execution phase of apoptosis may not hinge
upon caspase action alone. Instead, the transition might
involve activation of downstream factors. The CAD-like
nuclease appears to be largely inactive in freshly prepared
S/M extracts, becoming active only as the extracts are in-
cubated at 30 or 378C. This activation presumably reflects
the cleavage of ICAD/DFF45 by caspases since CAD acti-
vation is blocked by caspase inhibitors. In contrast, the
CAD-like nuclease activity appears to be fully active in
freshly prepared E/X extracts. Collectively, these observa-
tions suggest that caspase activation occurs during the la-
tent phase of apoptosis, whereas CAD activation accom-
panies the transition from the latent to execution phase ofSamejima et al. Nuclear Apoptosis Downstream of Caspases 237
apoptosis. One implication of this conclusion is that cells
might simultaneously contain active caspases and inactive
complexes of ICAD/DFF bound to CAD and possibly
other downstream factors. This would be possible if
caspases were segregated from their downstream targets
such as ICAD/DFF, possibly by being sequestered in a dif-
ferent cellular compartment. The onset of apoptotic exe-
cution might then be triggered not by activation of the
caspases but by a change in the localization of either
caspases or targets. An alternative explanation of our
data, that caspases are inactive in the cells from which S/M
extracts are made and become activated during prepara-
tion of the extract (Zapata et al., 1998), is unlikely for two
reasons. First, we previously demonstrated that caspase
activity in similar extracts prepared from latent phase HL-
60 cells was paralleled by cleavage of PARP and pro-
caspase-3 in vivo (Martins et al., 1997a). Second, the
caspase-3 activation observed during extract preparation
in the previous study was explained by the detergent-induced
release of granzyme B from cytoplasmic vesicles (Zapata
et al., 1998). In our study, detergents were avoided during
extract preparation, and cells lacking granzyme B were
used.
In support of the notion that caspases and their targets
might be segregated during the latent phase, we note that
procaspases have largely been observed in the cytoplasm
(Duan et al., 1996a; Krajewska et al., 1997; Mancini et al.,
1998) (Mesner, P.W., and S.H. Kaufmann, unpublished
observations) or mitochondria (Mancini et al., 1998),
whereas our subcellular fractionation studies have re-
vealed significant levels of active caspases within the nu-
cleus (Martins et al., 1997a,b). An additional study has in-
dicated that interference with nuclear transport renders
cells resistant to Fas-mediated apoptosis (Yasuhara et al.,
1997).
We have developed a novel vector to coordinately ex-
press CAD and ICAD in E. coli and have used this par-
tially purified CAD to demonstrate that CAD can induce
an apoptotic morphology in isolated nuclei, as confirmed
by both light and electron microscopy. This reaction does
not require ongoing caspase activity. This result is consis-
tent with earlier observations, indicating that addition of
micrococcal nuclease to isolated nuclei can cause clumping
of chromatin (Arends et al., 1990), although the pattern of
condensation seen with CAD more closely resembles that
seen in apoptotic cells. However, CAD does not appear to
be the only factor downstream of caspases that is capable
of inducing apoptotic nuclear changes. Addition of puri-
fied ICAD to either S/M or E/X extracts abolished all de-
tectable DNase activity against both chromosomal and
plasmid DNA substrates but did not abolish the ability of
those extracts to induce an apoptotic morphology in sub-
strate nuclei. This observation is consistent with previous
reports that morphologically normal apoptosis can occur
in the absence of internucleosomal DNA fragmentation in
vivo (Ucker et al., 1992b; Oberhammer et al., 1993; Saka-
hira et al., 1998). At present, the nature of the second
downstream factor(s) that promotes apoptotic chromatin
condensation is unknown. Although two recent studies
suggest that serine (Shimizu and Pommier, 1997) or cys-
teine proteases (Vaux et al., 1997) may be involved, the
fact that we can detect apoptotic morphological changes in
the presence of DEVD-fmk as well as a battery of serine,
cysteine, and acid protease inhibitors (see Materials and
Methods) suggest that the chromatin-condensing activity
might not be a protease. On the other hand, simultaneous
addition of both DEVD-fmk and ICAD to E/X extracts
abolished the induction of apoptotic morphology in sub-
strate nuclei. This result suggests that the morphogenic
factor either binds to ICAD or is regulated by other mole-
cules that interact with ICAD.
In summary, the experiments reported here demon-
strate that it is possible to use cell-free extracts for a bio-
chemical and functional dissection of the sequential
phases of the apoptotic pathway. Our studies reveal that
the transition from the latent to the execution phase of
apoptosis appears to be accompanied by a change from
caspase-dependent to caspase-independent mechanisms.
The discovery that caspases are capable of cleaving abun-
dant nuclear proteins like PARP (Lazebnik et al., 1994)
and the lamins (Lazebnik et al., 1995; Takahashi et al.,
1996; Orth et al., 1996; Rao et al., 1996), along with the ob-
servation that apoptotic nuclear fragmentation is absent in
caspase-3–null cells (Woo et al., 1998; Janicke et al., 1998),
led us and others to previously assume that caspases are
directly responsible for nuclear disassembly. However, the
inability of purified caspases to produce apoptotic mor-
phological changes in isolated nuclei, coupled with the in-
ability of caspase inhibitors to abolish the induction of
these morphological changes by E/X extracts, argues that
caspases are unlikely to be workhorses that are solely re-
sponsible for nuclear disassembly. Instead, the present re-
sults provide support for a view in which caspases play an
executive role in nuclear disassembly by activating factors
that in turn disassemble the nucleus. At least one of the
downstream activities is a CAD-like nuclease; but another
downstream activity capable of inducing nuclear morpho-
logical changes appears to be distinct from CAD.
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